Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02559532
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
T1D | 5-(4-METHOXYBIPHENYL-3-YL)-1,2,5- THIADIAZOLIDIN-3-ONE 1,1-DIOXIDE | A | 2BGD | 0.73 | |
YTT | (3S,6S)-3,6-bis(4-hydroxybenzyl)piperazine- 2,5-dione | A | 3G5H | 0.71 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4H | 0.73 | |
UA1 | N-(TERT-BUTOXYCARBONYL)-L-TYROSYL- N-METHYL-4-(SULFOAMINO)-L-PHENYLALANINAMIDE | A | 2I4G | 0.73 | |
K57 | 3-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL-BUTYRYL]- 5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID TERT- BUTYLAMIDE | B | 1MRX | 0.73 | |
K57 | 3-[2-HYDROXY-3-(3-HYDROXY-2-METHYL- BENZOYLAMINO)-4-PHENYL-BUTYRYL]- 5,5-DIMETHYL-THIAZOLIDINE-4-CARBOXYLIC ACID TERT- BUTYLAMIDE | A | 1MRW | 0.73 | |
JE2 | (R)-N-(2-METHYLBENZYL)-3-[(2S,3S)- 2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO- 4-PHENYLBUTANOYL]-5,5-DIMETHYL- 1,3-THIAZOLIDINE-4-CARBOXAMIDE | A,B | 1KZK | 0.72 | |
JE2 | (R)-N-(2-METHYLBENZYL)-3-[(2S,3S)- 2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO- 4-PHENYLBUTANOYL]-5,5-DIMETHYL- 1,3-THIAZOLIDINE-4-CARBOXAMIDE | B | 1MSM | 0.72 | |
JE2 | (R)-N-(2-METHYLBENZYL)-3-[(2S,3S)- 2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO- 4-PHENYLBUTANOYL]-5,5-DIMETHYL- 1,3-THIAZOLIDINE-4-CARBOXAMIDE | A,B | 2ANL | 0.72 | |
JE2 | (R)-N-(2-METHYLBENZYL)-3-[(2S,3S)- 2-HYDROXY-3-(3-HYDROXY-2-METHYLBENZOYL)AMINO- 4-PHENYLBUTANOYL]-5,5-DIMETHYL- 1,3-THIAZOLIDINE-4-CARBOXAMIDE | B | 1MSN | 0.72 | |
U04 | ({3-[1-(4-HYDROXY-2-OXO-2H-CHROMEN- 3-YL)-PROPYL]-PHENYLCARBAMOYL}- METHYL)-CARBAMIC ACID TERT-BUTYL ESTER | A | 4UPJ | 0.7 | |
135 | N-(4-CARBAMIMIDOYL-PHENYL)-2-HYDROXY- BENZAMIDE | B | 1GJA | 0.72 | |
GN8 | (Z)-3-BENZYL-5-(2-HYDROXY-3-NITROBENZYLIDENE)- 2-THIOXOTHIAZOLIDIN-4-ONE | A,B,C,D,E,F | 2P6F | 0.79 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A54 | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 3E5V | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A56 | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A53 | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A50 | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFH | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D | 3E5W | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 3BXC | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFF | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 3E5T | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 3BXB | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | B,D | 2A52 | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLG | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 3BXA | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 2V4E | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLI | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 1UIS | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,C,D,E,F, G,H | 1ZGQ | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B,G,H | 3CFA | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLH | 0.7 | |
NRQ | {(4Z)-4-(4-hydroxybenzylidene)- 2-[3-(methylthio)propanimidoyl]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 3BX9 | 0.7 | |
A48 | 4-[(DIMESITYLBORYL)(2,2,2-TRIFLUOROETHYL)AMINO]PHENOL | A,B | 2Q6J | 0.73 | |
OPB | 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE- 3,5-DIONE | A | 1Q7A | 0.73 | |
OPB | 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE- 3,5-DIONE | A,B | 2BXB | 0.73 | |
OPB | 4-BUTYL-1-(4-HYDROXYPHENYL)-2-PHENYLPYRAZOLIDINE- 3,5-DIONE | A | 2BXO | 0.73 | |
LI7 | (3E)-3-[(4-HYDROXYPHENYL)IMINO]- 1H-INDOL-2(3H)-ONE | A | 1YXX | 0.75 | |
4BG | N-[4-(benzyloxy)phenyl]glycinamide | A | 3CHO | 0.75 | |
4BS | 4-amino-N-[4-(benzyloxy)phenyl]butanamide | A | 3CHR | 0.72 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HHN | 0.71 | |
GNQ | N-[(1R)-1-[(BENZYLSULFONYL)METHYL]- 2-{[(1S)-1-METHYL-2-{[4-(TRIFLUOROMETHOXY)PHENYL]AMINO}ETHYL]AMINO}- 2-OXOETHYL]MORPHOLINE-4-CARBOXAMIDE | A,B | 2HH5 | 0.71 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 2H5Q | 0.7 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XQM | 0.7 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A,B | 2QLG | 0.7 | |
CH6 | {(4Z)-2-[(1S)-1-amino-3-(methylsulfanyl)propyl]- 4-[(4-hydroxyphenyl)methylidene]- 5-oxo-4,5-dihydro-1H-imidazol-1- yl}acetic acid | A | 1XA9 | 0.7 | |
3GV | (3S)-1-(2-hydroxyphenyl)-5-oxopyrrolidine- 3-carboxylic acid | A,B | 3GVB | 0.72 | |
LJ5 | N-(3,5-dibromo-4-hydroxyphenyl)benzamide | A,B | 3CN4 | 0.73 | |
AXL | 2-{1-[2-AMINO-2-(4-HYDROXY-PHENYL)- ACETYLAMINO]-2-OXO-ETHYL}-5,5-DIMETHYL- THIAZOLIDINE-4-CARBOXYLIC ACID | B | 1LL9 | 0.7 | |
DZ1 | N-(3,5-dibromo-4-hydroxyphenyl)- 2,6-dimethylbenzamide | A,B | 3ESN | 0.7 | |
Y13 | (2E)-3-(3,4-DIHYDROXYPHENYL)-N- [2-(4-HYDROXYPHENYL)ETHYL]ACRYLAMIDE | A | 2EW6 | 0.71 | |
4BQ | (2S)-2-amino-5-oxo-5-[(4-phenylmethoxyphenyl)amino]pentanoic acid | A | 3CHQ | 0.71 | |
012 | (4S)-N-[(1S,2R)-1-benzyl-3-{[3- (dimethylamino)benzyl]amino}-2- hydroxypropyl]-1-(3-methoxybenzyl)- 2-oxoimidazolidine-4-carboxamide | A,B,C | 3CKP | 0.73 | |
CRV | N-[1-(AMINOMETHYL)CYCLOPROPYL]- 3-(BENZYLSULFONYL)-N~2~-[(1S)-2,2,2- TRIFLUORO-1-(4-HYDROXYPHENYL)ETHYL]- L-ALANINAMIDE | A,B | 2FRA | 0.71 | |
TYL | N-(4-HYDROXYPHENYL)ACETAMIDE (TYLENOL) | B,C,D | 1TYM | 0.75 | |
TYL | N-(4-HYDROXYPHENYL)ACETAMIDE (TYLENOL) | B,C,D | 1TYL | 0.75 | |
TYL | N-(4-HYDROXYPHENYL)ACETAMIDE (TYLENOL) | A | 2OCU | 0.75 | |
TYL | N-(4-HYDROXYPHENYL)ACETAMIDE (TYLENOL) | A,B,C,D,F | 3DJI | 0.75 | |
TYL | N-(4-HYDROXYPHENYL)ACETAMIDE (TYLENOL) | A | 2DPZ | 0.75 | |
SD2 | N-(SULFANYLACETYL)TYROSYLPROLYLMETHIONINAMIDE | A,B | 1PWQ | 0.72 | |
DMC | 3-(4-DIETHYLAMINO-2-HYDROXY-PHENYL)- 2-METHYL-PROPIONIC ACID | G | 4GCH | 0.72 | |
L05 | 1-BENZYL-3-(4-METHOXYPHENYLAMINO)- 4-PHENYLPYRROLE-2,5-DIONE | A,B,C,D,E,F, G,H | 2ACL | 0.77 | |
901 | 2-[(4-{2-ACETYLAMINO-2-[4-(1-CARBOXY- 3-METHYLSULFANYL-PROPYLCARBAMOYL)- BUTYLCARBAMOYL]-ETHYL}-2-ETHYL- PHENYL)-OXALYL-AMINO]-BENZOIC ACID | A | 1NZ7 | 0.7 | |
FEN | N-(4-HYDROXYPHENYL)ALL-TRANS RETINAMIDE | A | 1FEL | 0.78 | |
4BO | (3S)-3-amino-4-oxo-4-[(4-phenylmethoxyphenyl)amino]butanoic acid | A | 3CHP | 0.73 |